Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -13.00M
June 30, 2026 -15.67M
March 31, 2026 -10.73M
December 31, 2025 -3.864M
September 30, 2025 -3.586M
June 30, 2025 -5.909M
March 31, 2025 -7.094M
December 31, 2024 -5.792M
September 30, 2024 -5.47M
June 30, 2024 -5.792M
March 31, 2024 -7.616M
December 31, 2023 -6.163M
September 30, 2023 -4.661M
June 30, 2023 -9.463M
Date Value
March 31, 2023 -11.74M
December 31, 2022 -9.574M
September 30, 2022 -6.803M
June 30, 2022 -11.90M
March 31, 2022 -10.75M
December 31, 2021 -7.868M
September 30, 2021 -5.577M
June 30, 2021 -6.047M
March 31, 2021 -10.77M
December 31, 2020
September 30, 2020
June 30, 2020 -2.767M
March 31, 2020 -6.46M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -2.902M
Zymeworks, Inc. -23.34M
Rhythm Pharmaceuticals, Inc. -3.062M
Cue Biopharma, Inc. -10.08M
Yarrow Bioscience, Inc. -89.96M